Lower Respiratory Tract Pathogens and Their Antimicrobial Susceptibility Pattern: A 5-Year Study.
antimicrobial resistance
antimicrobial stewardship
epidemiology
lower respiratory tract infections
nosocomial infections
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
13 Jul 2021
13 Jul 2021
Historique:
received:
21
05
2021
revised:
30
06
2021
accepted:
09
07
2021
entrez:
6
8
2021
pubmed:
7
8
2021
medline:
7
8
2021
Statut:
epublish
Résumé
Lower respiratory tract infections (LRTIs) are the most common infections in humans. It is estimated that 2.74 million deaths worldwide occur each year due to LRTIs. The aim of the study was to determine the frequency and antibiotic susceptibility pattern of microorganisms isolated from respiratory samples of patients with LRTIs. Between January 2015 and December 2019, a total of 7038 sputum and bronchoaspirate samples from suspected LRTI patients were collected. Among them, 2753 samples (39.1%) showed significant microbial growth on culture media. The LRTI rate was higher in patients with male gender (67.1%) and with age between 40-59 years (48.6%). The microorganism identification and antibiotic susceptibility testing were performed with Vitek 2. Out of 4278 isolates species, 3102 (72.5%) were Gram-negative bacteria, 1048 (24.5%) were Gram-positive bacteria, and 128 (3.0%) were
Identifiants
pubmed: 34356772
pii: antibiotics10070851
doi: 10.3390/antibiotics10070851
pmc: PMC8300710
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Mol Sci. 2021 Jun 17;22(12):
pubmed: 34204295
Antibiotics (Basel). 2020 Nov 28;9(12):
pubmed: 33260698
Intervirology. 2019;62(1):15-22
pubmed: 31117080
Ann Ig. 2018 Sep-Oct;30(5 Supple 2):1-6
pubmed: 30374506
Pathog Glob Health. 2015;109(7):309-18
pubmed: 26343252
Lancet Infect Dis. 2017 Nov;17(11):1133-1161
pubmed: 28843578
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
Respirology. 2007 Jan;12(1):81-7
pubmed: 17207030
Int J Infect Dis. 2012 May;16(5):e321-31
pubmed: 22387143
J Glob Infect Dis. 2010 Sep;2(3):275-83
pubmed: 20927290
Molecules. 2018 Mar 30;23(4):
pubmed: 29601469
BMC Infect Dis. 2021 May 13;21(1):440
pubmed: 33985445
J Chemother. 2017 Jun;29(3):154-158
pubmed: 27376439
Diagn Microbiol Infect Dis. 2002 Nov;44(3):301-11
pubmed: 12493178
Iran Biomed J. 2015;19(4):240-6
pubmed: 26220641
Microorganisms. 2020 Jul 13;8(7):
pubmed: 32668575
PLoS One. 2013 Sep 11;8(9):e75131
pubmed: 24040394
Eur Respir J Suppl. 2002 Jul;36:40s-53s
pubmed: 12168747
Open Microbiol J. 2018 Mar 30;12:34-40
pubmed: 29785214
J Clin Microbiol. 2011 Jan;49(1):269-74
pubmed: 20962147
Nat Rev Dis Primers. 2021 Apr 8;7(1):25
pubmed: 33833230
Cancer Genet Cytogenet. 1989 Jan;37(1):85-93
pubmed: 2917335
Pathog Glob Health. 2020 Dec;114(8):451-456
pubmed: 33012280
Front Microbiol. 2020 Jun 30;11:1480
pubmed: 32695092
Clin Microbiol Rev. 2005 Oct;18(4):657-86
pubmed: 16223952
Biomed Res Int. 2019 Apr 17;2019:4834396
pubmed: 31119172
J Clin Diagn Res. 2013 Feb;7(2):253-6
pubmed: 23543819
Emerg Microbes Infect. 2018 Mar 14;7(1):31
pubmed: 29535298
Microorganisms. 2020 Jan 23;8(2):
pubmed: 31979375
Interdiscip Perspect Infect Dis. 2012;2012:976273
pubmed: 23097666
J Bacteriol. 2008 Dec;190(24):8053-64
pubmed: 18931120
Bull World Health Organ. 2008 Jun;86(6):494-6
pubmed: 18568283
PLoS One. 2015 Oct 02;10(10):e0139836
pubmed: 26430738
Microbiol Mol Biol Rev. 1998 Sep;62(3):725-74
pubmed: 9729608
Infect Drug Resist. 2020 Dec 29;13:4713-4738
pubmed: 33402841
Clin Microbiol Infect. 2008 Dec;14 Suppl 6:2-8
pubmed: 19040461
Front Microbiol. 2019 Jan 22;9:3198
pubmed: 30723463
Expert Rev Anti Infect Ther. 2019 Dec;17(12):969-981
pubmed: 31722185
Am J Med Sci. 2017 Nov;354(5):471-475
pubmed: 29173358
Clin Microbiol Rev. 2007 Apr;20(2):368-89
pubmed: 17428889
Perspect Medicin Chem. 2014 Aug 28;6:25-64
pubmed: 25232278
J Family Med Prim Care. 2020 Mar 26;9(3):1407-1412
pubmed: 32509624